Company: BDRX
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001214659-25-006756
Chunk: 144

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-01
Form: DRS
Chunk 144
---
 any of our Depositary Shares or other securities convertible into or exercisable or exchangeable for our Depositary
Shares for 60 days after this offering is completed without the prior written consent of the underwriter.

The underwriter
may in its sole discretion and at any time without notice release some or all of the shares subject to lock-up agreements prior to the
expiration of the lock-up period. When determining whether or not to release shares from the lock-up agreements, the underwriter will
consider, among other factors, the security holder’s reasons for requesting the release, the number of shares for which the release
is being requested and market conditions at the time.

Indemnification

We have agreed
to indemnify the underwriter against certain liabilities, including certain liabilities under the Securities Act. If we are unable to
provide this indemnification, we have agreed to contribute to payments the underwriter may be required to make in respect of those liabilities.

Stock Exchange

Our Depositary
Shares are currently listed on the NASDAQ Capital Market under the symbol “BDRX”.

Determination of Offering Price and Exercise Price

The actual public
offering price of the securities we are offering, and the exercise price of the warrants and Pre-Funded Warrants included in the Units
that we are offering, were negotiated between us and the underwriter based on the trading of our Depositary Shares prior to the offering,
among other things. Other factors considered in determining the public offering price of the securities we are offering, as well as the
exercise price of the warrants included in the Units and Pre-Funded Warrants that we are offering, include our history and prospects,
the market price of our Depositary Shares on the NASDAQ Capital Market, the stage of development of our business, our business plans for
the future and the extent to which they have been implemented, an assessment of our management, the general conditions of the securities
markets at the time of the offering and such other factors as were deemed relevant.

Electronic Distribution

A prospectus in
electronic format may be made available on a website maintained by the underwriter. In connection with the offering, the underwriter or
selected dealers may distribute prospectuses electronically. No forms of electronic prospectus other than prospectuses that are printable
as Adobe® PDF will be used in connection with this offering.

Other than the
prospectus in electronic format, the information on the underwriter’s website and any information contained in any other website
maintained by the underwriter is not